Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Causes of hepatitis and potential therapies that may improve care presented in study

Causes of hepatitis and potential therapies that may improve care presented in study

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

Hepatitis B vaccination for inmates

Hepatitis B vaccination for inmates

Link between iron regulation and the immune system

Link between iron regulation and the immune system

Preclinical data on Histamine's ability to prevent liver damage

Preclinical data on Histamine's ability to prevent liver damage

Mayo Clinic debunks myths cancer myths

Mayo Clinic debunks myths cancer myths

Hepatitis C wonder drug Ribasphere gets approval from FDA

Hepatitis C wonder drug Ribasphere gets approval from FDA

Haemophilia Society President presents Hepatitis C (HCV) Facts to UK Government

Haemophilia Society President presents Hepatitis C (HCV) Facts to UK Government

Tiny Ribozyme package could be future treatment of Hepatitis B virus

Tiny Ribozyme package could be future treatment of Hepatitis B virus